Related Experiment Videos
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Andreas Meyer-Lindenberg1, Robert S Miletich, Philip D Kohn
1Unit on Integrative Neuroimaging, National Institute of Mental Health, National Institutes of Health, 10-4C101, 9000 Rockville Pike, Bethesda, Maryland 20892-1365, USA. andreasml@nih.gov
Nature Neuroscience
|February 28, 2002
Summary
Schizophrenia patients show abnormal dopamine function and prefrontal cortex (PFC) activity. Reduced PFC activation in patients predicted higher dopamine uptake, suggesting PFC dysfunction drives dopamine abnormalities in schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Radiology
Background:
- Schizophrenia is characterized by dysregulated dopaminergic neurotransmission.
- Prefrontal cortex (PFC) dysfunction is a hallmark of schizophrenia.
- The relationship between PFC function and dopaminergic abnormalities remains unclear.
Purpose of the Study:
- To investigate the link between presynaptic dopaminergic function and PFC activity in schizophrenia.
- To test the hypothesis that PFC dysfunction contributes to dopaminergic abnormalities.
Main Methods:
- Simultaneous measurement of striatal dopaminergic uptake (using 6-fluorodopa PET) and regional cerebral blood flow (during the Wisconsin Card Sorting Test [WCST] and a control task).
- Comparison between unmedicated schizophrenic subjects and matched healthy controls.
Main Results:
- Schizophrenia patients exhibited a significantly higher dopaminergic uptake constant (Ki) in the striatum compared to controls.
- Patients showed significantly reduced PFC activation during the WCST.
- A strong inverse correlation was observed between PFC activation and striatal dopamine uptake in patients, but not controls.
Conclusions:
- Decreased PFC activation in schizophrenia patients predicts exaggerated striatal dopamine uptake.
- These findings support the hypothesis that prefrontal cortex dysfunction is a key factor contributing to dopaminergic transmission abnormalities in schizophrenia.